YIH
TIL icon

Y-Intercept (HK)’s Instil Bio TIL Stock Holding History

Y-Intercept (HK)’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,074
Closed -$89K – 1592
2023
Q2 		$89K Buy
+8,074
New +$98.7K 0.01% 1127

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Y-Intercept (HK)'s TIL Position: Q3 2023 in Review

Y-Intercept (HK) sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 8,074 shares — an estimated $89K sold.

Y-Intercept (HK) first reported a position in TIL in Q2 2023 and held it in 1 quarter. The position peaked at $89K in Q2 2023. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

  • Y-Intercept (HK) reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 8,074 Instil Bio shares in Q3 2023, an estimated $89K.
  • Y-Intercept (HK) first reported a position in Instil Bio in Q2 2023 and held it in 1 quarter.
  • Y-Intercept (HK)'s Instil Bio position peaked at $89K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on Y-Intercept (HK)'s 13F filing for Q3 2023, filed 14 Nov 2023.